Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

被引:6
|
作者
Siddi, Sara [1 ,2 ]
Gine-Vazquez, Iago [1 ,2 ]
Bailon, Raquel [3 ,4 ]
Matcham, Faith [5 ,6 ]
Lamers, Femke [7 ,8 ]
Kontaxis, Spyridon [3 ,4 ]
Laporta, Estela [4 ]
Garcia, Esther [4 ,9 ]
Arranz, Belen [1 ,2 ]
Dalla Costa, Gloria [10 ]
Guerrero, Ana Isabel [11 ]
Zabalza, Ana [11 ]
Buron, Mathias Due [12 ]
Comi, Giancarlo [10 ,13 ]
Leocani, Letizia [10 ,14 ]
Annas, Peter [15 ]
Hotopf, Matthew [5 ]
Penninx, Brenda W. J. H. [7 ,8 ]
Magyari, Melinda [12 ]
Sorensen, Per S.
Montalban, Xavier [11 ]
Lavelle, Grace [5 ]
Ivan, Alina [5 ]
Oetzmann, Carolin [5 ]
White, Katie M. [5 ]
Difrancesco, Sonia [7 ]
Locatelli, Patrick [16 ]
Mohr, David C. [17 ]
Aguilo, Jordi [4 ,9 ]
Narayan, Vaibhav [18 ]
Folarin, Amos [5 ]
Dobson, Richard J. B. [5 ]
Dineley, Judith [5 ]
Leightley, Daniel [5 ]
Cummins, Nicholas [5 ]
Vairavan, Srinivasan [18 ]
Ranjan, Yathart [5 ]
Rashid, Zulqarnain [5 ]
Rintala, Aki [19 ,20 ]
De Girolamo, Giovanni [21 ]
Preti, Antonio [22 ]
Simblett, Sara [5 ]
Wykes, Til [5 ]
Myin-Germeys, Inez [19 ]
Haro, Josep Maria [1 ,2 ]
机构
[1] Parc Sanitari St Joan de Deu, Fundacio St Joan de Deu, CIBERSAM, Madrid 28029, Spain
[2] Univ Barcelona, Barcelona 08007, Spain
[3] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza 50001, Spain
[4] Ctr Invest Biomed Red Area Bioingn Biomat & Nanom, Madrid 28029, Spain
[5] Kings Coll London, Inst Psychiat, Psychol & Neurosci, London SE5 8AF, England
[6] Univ Sussex, Sch Psychol, Falmer BN1 9QH, England
[7] Vrije Univ, Dept Psychiat, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands
[8] Amsterdam Publ Hlth Res Inst, Mental Hlth Program, NL-1081 BT Amsterdam, Netherlands
[9] Univ Autonoma Barcelona, Microelect & Sistemas Elect, Bellaterra 08193, Spain
[10] Univ Vita Salute San Raffaele, Fac Med, I-20132 Milan, Italy
[11] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca,Dept Neurol Neuroimmuno, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona 08035, Spain
[12] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Rigshosp, DK-2100 Copenhagen, Denmark
[13] Casa Cura Policlin, I-20144 Milan, Italy
[14] Sci Inst San Raffaele, Inst Expt Neurol, Expt Neurophysiol Unit, INSPE, I-20132 Milan, Italy
[15] H Lundbeck & Co AS, DK-2500 Valby, Denmark
[16] Univ Bergamo, Dept Engn & Appl Sci, I-24129 Bergamo, Italy
[17] Northwestern Univ, Ctr Behav Intervent Technol, Dept Preventat Med, Chicago, IL 60611 USA
[18] Janssen Res & Dev LLC, Res & Dev Informat Technol, Titusville, NJ 08560 USA
[19] Katholieke Univ Leuven, Ctr Contextual Psychiat, Dept Neurosci, B-7001 Leuven, Belgium
[20] LAB Univ Appl Sci, Fac Social Serv & Hlth Care, Lahti 15210, Finland
[21] IRCCS Inst Ctr San Giovanni Dio Fatebenefratelli, I-25125 Brescia, Italy
[22] Univ Torino, Dipartimento Neurosci, I-10126 Turin, Italy
关键词
COVID-19; SARS-CoV-2; major depressive disorder; multiple sclerosis; depression severity; heart rate; stress; social activity; physical activity; decentralized; HEART-RATE-VARIABILITY; STRESSFUL LIFE EVENTS; MENTAL-HEALTH; SEDENTARY BEHAVIOR; IMPACT; METAANALYSIS; ASSOCIATION; VALIDITY; ANXIETY; RISK;
D O I
10.3390/jcm11237163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS). Methods: Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Results: Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Conclusions: Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] COVID-19 vaccination willingness among people with multiple sclerosis
    Xiang, Xinran M.
    Hollen, Chris
    Yang, Qian
    Brumbach, Barbara H.
    Spain, Rebecca, I
    Wooliscroft, Lindsey
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [22] Correspondence on COVID-19 vaccination uptake in people with multiple sclerosis
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    ACTA NEUROLOGICA BELGICA, 2024, 124 (01) : 349 - 349
  • [23] Psychosocial Impacts of COVID-19 in People Living with Multiple Sclerosis
    Uhr, Lauren E.
    Schmidt, Hollie
    Rice, Dylan R.
    Loud, Sara
    McBurney, Robert
    Mateen, Farrah J.
    ANNALS OF NEUROLOGY, 2021, 90 : S178 - S179
  • [24] Correspondence on COVID-19 vaccination uptake in people with multiple sclerosis
    Amnuay Kleebayoon
    Viroj Wiwanitkit
    Acta Neurologica Belgica, 2024, 124 : 349 - 349
  • [25] A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis
    Amtmann, Dagmar
    Bamer, Alyssa M.
    Johnson, Kurt L.
    Ehde, Dawn M.
    Beier, Meghan L.
    Elzea, Jamie L.
    Bombardier, Charles H.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 79 (06) : 550 - 557
  • [26] Multiple sclerosis and COVID-19
    Mares, Jan
    Hartung, Hans-Peter
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (03): : 217 - 225
  • [27] COVID-19 (inactivated and mRNA) vaccine and humoral response in people with multiple sclerosis: Chilean cohort
    Galleguillos, L.
    Pallauta, K.
    Jerez, M. E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 581 - 582
  • [28] The Impact of COVID-19 Lockdown on Parents and Young People With Autism Spectrum Disorder (ASD)
    Humphreys, Cathy
    Novy, Louis
    Cergovski, Natalie
    Lai, Hoi Ching
    McVilly, Keith
    AUSTRALIAN SOCIAL WORK, 2024, 77 (02) : 183 - 195
  • [29] Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
    Júlia Leão Batista Simões
    Agatha Carina Leite Galvan
    Eduarda Luiza Maciel da Silva
    Zuleide Maria Ignácio
    Margarete Dulce Bagatini
    Cellular and Molecular Neurobiology, 2023, 43 : 621 - 637
  • [30] Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19
    Batista Simoes, Julia Leao
    Leite Galvan, Agatha Carina
    Maciel da Silva, Eduarda Luiza
    Ignacio, Zuleide Maria
    Bagatini, Margarete Dulce
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (02) : 621 - 637